Author:
Chen Katherine S.,Braunstein Steve E.,Gottschalk Alexander R.
Publisher
Springer International Publishing
Reference40 articles.
1. American Cancer Society. Cancer facts and figures. 2021. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf. Accessed 18 Mar 2021.
2. Baumann BC, Bernstein KDA, DeLaney TF, Simone CB, Kolker JD, Choy E, et al. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: high rates of local control with favorable toxicity. J Surg Oncol. 2020;122(5):877–83.
3. Billingsley KG, Burt ME, Jara E, Ginsberg RJ, Woodruff JM, Leung DHY, et al. Pulmonary metastases from soft tissue sarcoma: analysis of patterns of disease and postmetastasis survival. Ann Surg. 1999;229(5):602–12.
4. Bishop AJ, Tao R, Guadagnolo BA, Allen PK, Rebueno NC, Wang XA, et al. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. J Neurosurg Spine. 2017;27(3):303–11.
5. Chang EL, Selek U, Hassenbusch SJ, Maor MH, Allen PK, Mahajan A, et al. Outcome variation among “radioresistant” brain metastases treated with stereotactic radiosurgery. Neurosurgery. 2005;56(5):936–44.